𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Development of a testicular haemangioma after interferon therapy for hepatic haemangiomas: a case report

✍ Scribed by S. Yanai; H. Tsutsumi; T. Hotsubo; A. Takahashi; N. Miyao; M. Satoh; S. Chiba


Publisher
Springer
Year
1997
Tongue
English
Weight
758 KB
Volume
156
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Characteristics of patients with chronic
✍ Akiko Makiyama; Yoshito Itoh; Akinori Kasahara; Yasuharu Imai; Sumio Kawata; Ken πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 3 views

## Abstract ## BACKGROUND The objective of the current study was to determine the characteristic features of sustained responders who develop hepatocellular carcinoma after treatment with interferon for chronic hepatitis C. ## METHODS This study included 3626 patients with chronic hepatitis C wh

A simple noninvasive index for predictin
✍ Ming-Lung Yu; Shi-Ming Lin; Chuan-Mo Lee; Chia-Yen Dai; Wen-Yu Chang; Shinn-Cher πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 270 KB πŸ‘ 2 views

Changes in hepatic fibrosis after interferon-based therapy may be important in determining the long-term outcome of chronic hepatitis C (CHC). The use of liver biopsy for posttreatment assessment is not a viable option as a routine follow-up procedure. This study evaluated the predictive value of a

Case report: Cure of chronic infection w
✍ Anne Rachline; Pierre Palmer; FranΓ§ois Simon; Jean-Michel Molina πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 57 KB

## Abstract The recommended treatment duration of chronic hepatitis C virus (HCV) in patients infected with human immunodeficiency virus (HIV) is 48 weeks. This report describes a patient co‐infected with HCV genotype 2 and HIV who discontinued HCV therapy after 6 weeks because of adverse events an